SynthesisWorld journal of urology2026
Vibegron, mirabegron, and other add-on therapies for persistent overactive bladder symptoms in α1-blocker-treated men with benign prostatic hyperplasia: a systematic review and Bayesian network meta-analysis.
Shugo Yajima et al.PubMed ↗Publisher ↗
No numbers read from the abstract.